Bortemap 2mg Bortezomib Injection Description:
Bortemap 2mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cancer cells.
Uses:
Bortemap 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
Side Effects:
Low blood platelets, Fatigue, Peripheral neuropathy, Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia, Diarrhoea, Decreased appetite, Neutrophils, Constipation.
Dosage:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
FAQs
Is Bortemap 2mg a chemotherapy/hormonal drug/ cytotoxic?
Bortemap 2mg is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma
How does Bortemap 2mg work?
Bortemap 2mg belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells
Is Bortemap 2mg FDA approved?
Yes, Bortemap 2mg is approved by FDA
Is Bortemap 2mg dialyzable?
Yes, Bortemap 2mg is dialyzable
Is Bortemap 2mg toxic?
Bortemap 2mg can cause toxic effects if not given in appropriate dose although not everybody gets them
Reviews
There are no reviews yet.